QURE · NASDAQ · Biotechnology

uniQure (QURE)

Develops one-time AAV gene therapies for serious diseases with unmet needs.

$45.70
After-hours close+0.43 (+0.95%)
At close$45.27(+2.17%)
  1. Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?

    Zacks Investment ResearchMarket move